SCHEMBL24307263

SCHEMBL24307263

CCC1(CCNC)Oc2ccc(C)cc2NC1=O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.40
▸ USP2 O75604 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ CREBBP Q92793 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ THRB P10828 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24307264 0.83 MMP12 (0.40) MMP12USP2GAABRD4CREBBP
SCHEMBL25936932 0.73 MMP12 (0.42) MMP12USP2GAABRD4CREBBP
SCHEMBL89103 0.70 KDM4E (0.56) MMP12USP2GAABRD4CREBBP
SCHEMBL8265565 0.69 MMP12 (0.50) MMP12USP2GAABRD4CREBBP
SCHEMBL24306740 0.69 MAPT (0.42) GAABRD4CREBBPKDM4EALDH1A1
SCHEMBL13090980 0.68 MMP12 (0.53) MMP12USP2GAABRD4CREBBP
SCHEMBL24307261 0.66 MMP12 (0.50) MMP12USP2GAABRD4CREBBP
SCHEMBL24306751 0.66 MMP12 (0.50) MMP12USP2GAABRD4CREBBP
SCHEMBL26766724 0.66 MMP12 (0.50) MMP12USP2GAABRD4CREBBP
SCHEMBL26766745 0.66 MMP12 (0.50) MMP12USP2GAABRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219461-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF Medshine Discovery Inc. (CN) 2023-08-02 — — EP disclosed
WO-2022063094-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF 南京明德新药研发有限公司 2022-03-31 — — WO disclosed
Send feedback